Foundayo (Orforglipron) Emerging Oral GLP-1 FDA-approved for: Weight loss in adults (as of February 2026) Dosing: Once daily by mouth, with or without food Device: Oral tablet Foundayo represents a new chemical class
Understanding the Strategic Importance of Launching a GHK-Cu Peptide Serum Whenever I speak with brand founders who are considering launching a copper peptide serum, I always emphasize that the ingredient itself is only part of the strategy
Roig I, Dowdle JA, Toth A, de Rooij DG, Jasin M, Keeney S
Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Profound sedation, respiratory depression, coma, and death may result from the concomitant use of oxycodone and acetaminophen tablets with benzodiazepines and/or other CNS depressants, including alcohol (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids, [gabapentin or pregabalin] and other opioids)
This may be because these parts of the body are cooler, and low temperatures make it more likely for crystals to form